ArticleFrontiers in medicine2025
COPD-MMDDxNet: a multimodal deep learning framework for accurate COPD diagnosis using electronic medical records.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
COPD affects approximately 391 million people globally. While spirometry is recognized as the gold standard for diagnosing COPD according to the GOLD guidelines, its availability is limited in primary healthcare settings, particularly in low- and middle-income countries. Furthermore, spirometry requires patient cooperation, which may be challenging for individuals with physical limitations or comorbidities, potentially impacting its accuracy. As a result, there is a need for alternative diagnostic methods, particularly those suited for resource-constrained environments. This study proposes a novel multimodal deep learning framework, COPD-MMDDxNet, which integrates structured pulmonary CT reports, blood gas analysis, and hematological analysis from electronic medical records (EMRs) to overcome the limitations of existing diagnostic methods. This framework develops the first multimodal diagnostic tool for COPD that does not rely on spirometry. It innovatively fuses cross-modal data, incorporating four key components: parametric numerical embedding, hierarchical interaction mechanisms, contrastive regularization strategies, and dynamic fusion coefficients. These innovations significantly enhance the model's ability to capture complex cross-modal relationships, thereby improving diagnostic accuracy.The dataset used in this study comprises 800 COPD patients, with a balanced age and sex distribution, and data were collected over a 24-month period. Experimental results demonstrate that COPD-MMDDxNet outperforms traditional single-modality models and other state-of-the-art multimodal models in terms of accuracy (81.76%), precision (78.87%), recall (77.78%), and F1 score (78.32%). Ablation studies confirm the critical importance of each model component, particularly the contrastive learning module and cross-modal attention mechanism, in enhancing model performance.This framework offers a robust solution for more accurate and accessible COPD diagnosis, particularly in resource-constrained environments, without the need for spirometry.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.